Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.31 |
| ▸ | ACP1 | P24666 | 2/20 | 0.31 |
| ▸ | CDC25B | P30305 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7237918 | 0.85 | PTPN1 (0.35) | ALDH1A1ACHETSHRHPGDSMN1; SMN2 | |
| SCHEMBL12844899 | 0.83 | ACHE (0.32) | ACHETSHR | |
| SCHEMBL3370983 | 0.83 | ACHE (0.32) | ACHETSHRPTPN1 | |
| SCHEMBL6948155 | 0.83 | ACHE (0.32) | ACHETSHR | |
| SCHEMBL7682479 | 0.83 | ACHE (0.32) | ALDH1A1ACHETSHR | |
| SCHEMBL12779376 | 0.83 | ACHE (0.32) | ACHETSHR | |
| SCHEMBL5565195 | 0.81 | TDP1 (0.43) | ALDH1A1ACHEPTPN1ACP1CDC25B | |
| SCHEMBL178866 | 0.79 | L3MBTL1 (0.32) | ACHE | |
| SCHEMBL21751797 | 0.78 | PTPN1 (0.32) | PTPN1ACP1CDC25B | |
| SCHEMBL4439425 | 0.78 | LMNA (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-62249971-A | — | — | None | — | — | JP | disclosed |
| US-20250098679-A1 | HERBICIDAL PYRIDONE DERIVATIVES | SYNGENTA CROP PROTECTION AG (CH) | 2025-03-27 | — | — | US | disclosed |
| EP-4448509-A1 | HERBICIDAL PYRIDONE DERIVATIVES | Syngenta Crop Protection AG (CH) | 2024-10-23 | — | — | EP | disclosed |
| CN-118355007-A | Herbicidal pyridone derivatives | 先正达农作物保护股份公司 | 2024-07-16 | — | — | CN | disclosed |
| WO-2023171665-A1 | PIPERIDINONE DERIVATIVE OR SALT THEREOF, HARMFUL ORGANISM CONTROL AGENT CONTAINING SAID COMPOUND, AND METHOD FOR USING SAME | 株式会社ADEKA | 2023-09-14 | — | — | WO | disclosed |
| WO-2023110664-A1 | HERBICIDAL PYRIDONE DERIVATIVES | SYNGENTA CROP PROTECTION AG (CH) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023110664-A1 | HERBICIDAL PYRIDONE DERIVATIVES | SYNGENTA CROP PROTECTION AG (CH) | 2023-06-22 | — | — | WO | disclosed |
| WO-2014181000-A1 | PRODUCTION OF MYXOPYRONIN AND OF ITS DERIVATIVES | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2014-11-13 | — | — | WO | disclosed |
| US-6608086-B2 | Selective adrenergic receptor alpha 1C antagonists without significant calcium channel activity; treating benign prostatic hyperplasia, intraocular pressure and inhibiting cholesterol synthesis | SYNAPTIC PHARMACEUTICAL CORPORATION | 2003-08-19 | — | — | US | disclosed |
| US-20020193599-A1 | Dihydropyridines and new uses thereof | SYNAPTIC PHARMACEUTICAL CORPORATION | 2002-12-19 | — | — | US | disclosed |
| US-6310076-B1 | TREATING BENIGN PROSTATIC HYPERPLASIA, LOWERING INTRAOCULAR PRESSURE, INHIBITING CHOLESTEROL SYNTHESIS, TREATING DISEASES MEDIATED BY ALPHA-1 RECEPTORS | SYNAPTIC PHARMACEUTICAL CORPORATION | 2001-10-30 | — | — | US | disclosed |
| US-6211198-B1 | BENIGN PROSTATE HYPERPLASIA; INTRAOCULAR PRESSURE; HYPOTENSIVE AGENTS | SYNAPTIC PHARMACEUTICAL CORPORATION | 2001-04-03 | — | — | US | disclosed |
| EP-1015412-A1 | SUBSTITUTED ALKENOIC ACIDS AND THEIR DERIVATIVES | BAYER AG (DE) | 2000-07-05 | — | — | EP | disclosed |
| EP-1015420-A1 | SUBSTITUTED ALKENOIC ACIDS AND THEIR DERIVATIVES | BAYER AG (DE) | 2000-07-05 | — | — | EP | disclosed |
| WO-1999012892-A1 | SUBSTITUTED ALKENOIC ACIDS AND THEIR DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1999-03-18 | — | — | WO | disclosed |
| WO-1999012885-A1 | SUBSTITUTED ALKENOIC ACIDS AND THEIR DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1999-03-18 | — | — | WO | disclosed |
| US-5767131-A | TREATMENT OF BENIGN PROSTATIC HYPERPLASIA, INHIBITION OF CHOLESTEROL SYNTHESIS, LOWERING OF INTRAOCULAR PRESSURE; ALPHA-ADRENERGIC RECEPTOR DISEASES | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 1998-06-16 | — | — | US | disclosed |
| WO-1994022829-A2 | DIHYDROPYRIDINES AND NEW USES THEREOF | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 1994-10-13 | — | — | WO | disclosed |
| JP-S62249971-A | PRODUCTION OF PYRIDONE-3-CARBOXAMIDE DERIVATIVE | DAICEL CHEM IND LTD | 1987-10-30 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250098679-A1 | HERBICIDAL PYRIDONE DERIVATIVES | PDXK, DDT, PNPO | ALDH1A1 46/4885ACHE 55/4885TSHR 2469/4885 |
| US-20020193599-A1 | Dihydropyridines and new uses thereof | BPHL, BCKDK, DHCR7 | ALDH1A1 1118/4885ACHE 1050/4885TSHR 3360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.